According to our (Global Info Research) latest study, the global Pepsinogen Test Kits market size was valued at US$ 119 million in 2025 and is forecast to a readjusted size of US$ 165 million by 2032 with a CAGR of 4.9% during review period.
Pepsinogen detection kits are in vitro diagnostic products designed to measure serum or plasma levels of PGI, PGII, and the PGI/PGII ratio; they serve as an aid in assessing gastric mucosal atrophy, evaluating gastric cancer risk, and screening for gastric diseases.
The upstream supply chain comprises antigens and antibodies, raw materials for enzyme-linked and chemiluminescence assays, colloidal gold materials, calibrators, quality control standards, packaging materials, and components for detection instruments. The downstream market consists of hospital clinical laboratories, health examination centers, third-party medical laboratories, and primary care screening institutions.
Globally, the average unit price for pepsinogen detection kits stands at $253 per kit, with an annual sales volume of approximately 458,000 kits. The industry possesses an annual production capacity of 1 to 1.5 million kits, maintaining a profit margin of approximately 40%.
Moving forward, the global market is expected to be driven by advancements in early screening for gastric cancer, the management of chronic digestive system diseases, and the widespread adoption of routine health checkups, leading to a sustained increase in demand for testing. Chemiluminescence, immunochromatography, and multi-marker combined testing are poised to become the dominant technological trends, with future products placing greater emphasis on sensitivity, compatibility with automated systems, and result standardization. As screening systems mature in high-incidence regions across Asia—and as the scope of primary care and home-based rapid testing expands—industry competition is expected to shift from the mere supply of reagents toward the provision of integrated services encompassing reagents, instrumentation, data interpretation, and comprehensive screening solutions.
This report is a detailed and comprehensive analysis for global Pepsinogen Test Kits market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Pepsinogen Test Kits market size and forecasts, in consumption value ($ Million), sales quantity (K Boxes), and average selling prices (US$/Box), 2021-2032
Global Pepsinogen Test Kits market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Boxes), and average selling prices (US$/Box), 2021-2032
Global Pepsinogen Test Kits market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Boxes), and average selling prices (US$/Box), 2021-2032
Global Pepsinogen Test Kits market shares of main players, shipments in revenue ($ Million), sales quantity (K Boxes), and ASP (US$/Box), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pepsinogen Test Kits
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pepsinogen Test Kits market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BIOHIT HealthCare Oyj, Fujirebio Holdings, FUJIFILM Wako Pure Chemical Corporation, Eiken Chemical, Shima Laboratories, Shenzhen New Industries Biomedical Engineering, Autobio Diagnostics, ACON Biotech (Hangzhou), Tellgen Corporation, Hangzhou Biotest Biotech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Pepsinogen Test Kits market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Pepsinogen I (PG I) Detection Kit
Pepsinogen II (PG II) Detection Kit
PG I/PG II Ratio Detection Kit
PG I + PG II Combined Detection Kit
Market segment by Sample Type
Serum Detection Kit
Plasma Detection Kit
Whole Blood Detection Kit
Peripheral Blood Rapid Detection Kit
Market segment by Detection Method
Enzyme-Linked Immunosorbent Assay (ELISA)
Chemiluminescence Immunoassay (CLIA)
Colloidal Gold Method
Fluorescence Immunochromatography
Others
Market segment by Application
Hospital
Clinic
Major players covered
BIOHIT HealthCare Oyj
Fujirebio Holdings
FUJIFILM Wako Pure Chemical Corporation
Eiken Chemical
Shima Laboratories
Shenzhen New Industries Biomedical Engineering
Autobio Diagnostics
ACON Biotech (Hangzhou)
Tellgen Corporation
Hangzhou Biotest Biotech
Ebiotron Biotech
Vacure Biotechnology
Epitope Diagnostics
Thermo Fisher Scientific
RayBiotech
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pepsinogen Test Kits product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pepsinogen Test Kits, with price, sales quantity, revenue, and global market share of Pepsinogen Test Kits from 2021 to 2026.
Chapter 3, the Pepsinogen Test Kits competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pepsinogen Test Kits breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Pepsinogen Test Kits market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pepsinogen Test Kits.
Chapter 14 and 15, to describe Pepsinogen Test Kits sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Pepsinogen Test Kits. Industry analysis & Market Report on Pepsinogen Test Kits is a syndicated market report, published as Global Pepsinogen Test Kits Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Pepsinogen Test Kits market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.